Dark
Light
System
Institutional Investment Manager
Cheyne Capital Management (UK) LLP
Cheyne Capital Management (UK) LLP (CIK: 0001390457), located at Stornoway House, London, X0. Institutional holdings reported to the SEC.

Institutional Holdings (2015Q3)
Portfolio Summary: 41 holdings with a total value of $213,199,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 SUNOCO LP/SUNOCO FIN CORP 368,500 36,138,000 16.95%
2 CYTEC INDUSTRIES INC 488,937 36,115,000 16.94%
3 STRATEGIC HOTELS & RESORTS I 1,777,481 24,538,000 11.51%
4 CABLEVISION SYS CORP(NEW) NY GROUP CL ACOM 746,549 24,229,000 11.36%
5 PRECISION CASTPARTS 76,500 17,575,000 8.24%
6 ALTERA CORPORATION 300,097 15,026,000 7.05%
7 HOME PROPERTIES INC 187,903 14,050,000 6.59%
8 SANDISK CORP 3,000,000 3,730,000 1.75% PRN
9 CLOVIS ONCOLOGY INC NOTE 2,000,000 3,325,000 1.56% PRN
10 CITRIX SYS INC 3,000,000 3,157,000 1.48% PRN
11 Orexigen Therapeutics, Inc. 1,215,392 2,558,000 1.20%
12 SALESFORCE COM 2,000,000 2,438,000 1.14% PRN
13 WELLS FARGO & CO NEW 40,315 2,068,000 0.97%
14 CEPHEID 2,000,000 2,030,000 0.95% PRN
15 SYNCHRONOSS TECHNOLOGIES INC NOTE 0.750 8/1 2,000,000 2,020,000 0.95% PRN
16 NEKTAR THERAPEUTICS COM 172,306 1,889,000 0.89%
17 INFINITY PHARMACEUTICALS INC COM 220,618 1,863,000 0.87%
18 ACORDA THERAPEUTICS INC 2,000,000 1,826,000 0.86% PRN
19 INTERCEPT PHARMACEUTICAL 10,150 1,682,000 0.79%
20 CTRIP COM INTL LTD 1,500,000 1,625,000 0.76% PRN
21 RADNET INC COM 280,000 1,555,000 0.73%
22 PROLOGIS INC 39,268 1,528,000 0.72%
23 DUKE REALTY CORP 79,278 1,511,000 0.71%
24 EMERGENT BIOSOLUTIONS INC NOTE 1,250,000 1,415,000 0.66% PRN
25 VANDA PHARMACEUTICALS INC COM 109,000 1,228,000 0.58%
26 TRAVELERS COMPANIES INC 11,000 1,095,000 0.51%
27 MASTERCARD INCORPORATED 12,000 1,081,000 0.51%
28 RTI INTL METALS INC 1,000,000 1,046,000 0.49% PRN
29 EDGEWELL PERS CARE 10,000 816,000 0.38%
30 CRITEO SA 18,599 698,000 0.33%
31 WMI HOLDINGS CORP. 220,000 573,000 0.27%
32 ADAMAS PHARMACEUTICALS INC 30,000 502,000 0.24%
33 INOVIO PHARMACEUTICALS INC 70,000 404,000 0.19%
34 KINROSS GOLD CORP 215,000 371,000 0.17%
35 OREXIGEN THERAPEUTICS INC 500,000 347,000 0.16% PRN
36 BARRICK GOLD CORP 50,000 318,000 0.15%
37 KINDER MORGAN INCORPORATED DEL WARRANT EXP 052517 285,000 259,000 0.12% PRN
38 AURINIA PHARMACEUTICALS INC 90,000 257,000 0.12%
39 ALIMERA SCIENCES INC 73,000 161,000 0.08%
40 OncoGenex Pharmaceuticals Inc 62,000 137,000 0.06%
41 QIHOO 360 TECHNOLOGY CO LTD 4,000,000 15,000 0.01% PRN

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-15-037930, filed 2015.10.19).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.